Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphism

Clinical Pharmacology and Therapeutics

Volumn 46, Issue 2, 1989, Pages 149-154

  Lennard, Lynne ^a,b   Van Loon, Jon A ^a,b   Weinshilboum, Richard M ^a,b  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; THIOPURINE METHYLTRANSFERASE;

ADULT; AGED; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; DRUG METABOLISM; DRUG TOXICITY; FEMALE; GENETIC POLYMORPHISM; HEREDITY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PHARMACOGENETICS; PRIORITY JOURNAL;

ADULT; AZATHIOPRINE; BONE MARROW; ERYTHROCYTES; FEMALE; GUANINE NUCLEOTIDES; HUMAN; MALE; METHYLTRANSFERASES; MIDDLE AGE; POLYMORPHISM (GENETICS); SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THIONUCLEOTIDES;

EID: 0024451147     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.1989.119     Document Type: Article

References (23)